329 related articles for article (PubMed ID: 22628054)
1. Inflammatory markers in coronary artery disease.
Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
[TBL] [Abstract][Full Text] [Related]
2. [Markers of inflammatory process in stable and unstable coronary artery disease].
Okopień B; Basiak M; Madej A; Labuzek K; Belowski D; Haberka M; Herman ZS
Pol Merkur Lekarski; 2006 Jul; 21(121):69-72. PubMed ID: 17007298
[TBL] [Abstract][Full Text] [Related]
3. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
Anderson JL
Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker.
Toth PP; McCullough PA; Wegner MS; Colley KJ
Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):425-38. PubMed ID: 20222820
[TBL] [Abstract][Full Text] [Related]
6. [High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease].
Silva D; Pais de Lacerda A
Rev Port Cardiol; 2012 Nov; 31(11):733-45. PubMed ID: 23046630
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in coronary artery diseases.
Li JJ
Chin Med J (Engl); 2011 Nov; 124(21):3568-75. PubMed ID: 22340179
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory biomarkers in coronary artery disease.
Zakynthinos E; Pappa N
J Cardiol; 2009 Jun; 53(3):317-33. PubMed ID: 19477372
[TBL] [Abstract][Full Text] [Related]
9. [The role of inflammation in the pathogenesis of atherosclerosis].
Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
Przegl Epidemiol; 2004; 58(4):663-70. PubMed ID: 15810508
[TBL] [Abstract][Full Text] [Related]
10. Markers of inflammation and their clinical significance.
Ballantyne CM; Nambi V
Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, C-reactive protein, and atherothrombosis.
Ridker PM; Silvertown JD
J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events.
Futterman LG; Lemberg L
Am J Crit Care; 2002 Sep; 11(5):482-6. PubMed ID: 12233975
[TBL] [Abstract][Full Text] [Related]
13. [Expression of chemokines and cytokines in atherosclerotic plaques and internal membrane of the arteries in patients with coronary artery disease].
Kukhtina NB; Aref'eva TI; Aref'eva AM; Akchurin RS; Krasnikova TL
Ter Arkh; 2008; 80(4):63-9. PubMed ID: 18491584
[TBL] [Abstract][Full Text] [Related]
14. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events.
Cola C; Clementi E; Biondi-Zoccai G; Sangiorgi G
Acta Chir Belg; 2007; 107(2):129-42. PubMed ID: 17515260
[TBL] [Abstract][Full Text] [Related]
15. [Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C. New insights or redundant information?].
Piñón P; Kaski JC
Rev Esp Cardiol; 2006 Mar; 59(3):247-58. PubMed ID: 16712749
[TBL] [Abstract][Full Text] [Related]
16. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].
Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G
Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076
[TBL] [Abstract][Full Text] [Related]
17. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
Trepels T; Zeiher AM; Fichtlscherer S
Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
[TBL] [Abstract][Full Text] [Related]
18. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis.
Dod HS; Bhardwaj R; Sajja V; Weidner G; Hobbs GR; Konat GW; Manivannan S; Gharib W; Warden BE; Nanda NC; Beto RJ; Ornish D; Jain AC
Am J Cardiol; 2010 Feb; 105(3):362-7. PubMed ID: 20102949
[TBL] [Abstract][Full Text] [Related]
19. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
Ismail A; Khosravi H; Olson H
Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
[TBL] [Abstract][Full Text] [Related]
20. [Dietary therapy for prevention and treatment of atherosclerosis from the perspective of anti-inflammation].
Tada N
Nihon Rinsho; 2011 Jan; 69(1):110-8. PubMed ID: 21226270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
